1 | care management government solutions | | | | | | | 3 | 1.11% |
2 | careers contact contact us | | | | | | | 3 | 1.11% |
3 | newsroom careers contact contact | | | | | | | 3 | 1.11% |
4 | resource library videos blog | | | | | | | 3 | 1.11% |
5 | about us sponsors overview | | | | | | 3 | 1.11% |
6 | management government solutions about | | | | | | | 3 | 1.11% |
7 | physician office remote care | | | | | | | 2 | 0.74% |
8 | blog newsroom careers contact | | | | | | | 2 | 0.74% |
9 | videos blog newsroom careers | | | | | | | 2 | 0.74% |
10 | overview sponsorship opportunities resources | | | | | | 2 | 0.74% |
11 | sponsors overview sponsorship opportunities | | | | | | 2 | 0.74% |
12 | us sponsors overview sponsorship | | | | | | 2 | 0.74% |
13 | remote care management government | | | | | | | 2 | 0.74% |
14 | office remote care management | | | | | | | 2 | 0.74% |
15 | library videos blog newsroom | | | | | | | 2 | 0.74% |
16 | across the care journey | | | | | | | 2 | 0.74% |
17 | matched pair analysis using | | | | | | | 1 | 0.37% |
18 | flu vaccines 20 increase in | | | | | | | 1 | 0.37% |
19 | cessation counseling and mammograms | | | | | | | 1 | 0.37% |
20 | colon cancer screenings tobacco | | | | | | | 1 | 0.37% |
21 | and colon cancer screenings | | | | | | | 1 | 0.37% |
22 | cervical and colon cancer | | | | | | | 1 | 0.37% |
23 | vaccines 20 increase in colon | | | | | | | 1 | 0.37% |
24 | for cervical and colon | | | | | | | 1 | 0.37% |
25 | 20 increase in colon cancer | | | | | | | 1 | 0.37% |
26 | screenings 11 increase in cervical | | | | | | | 1 | 0.37% |
27 | 11 increase in cervical cancer | | | | | | | 1 | 0.37% |
28 | impact for cervical and | | | | | | | 1 | 0.37% |
29 | of matched pair analysis | | | | | | | 1 | 0.37% |
30 | total impact for cervical | | | | | | | 1 | 0.37% |
31 | 12month total impact for | | | | | | | 1 | 0.37% |
32 | in cervical cancer screenings | | | | | | | 1 | 0.37% |
33 | cervical cancer screenings source | | | | | | | 1 | 0.37% |
34 | cancer screenings source results | | | | | | | 1 | 0.37% |
35 | longitudinal patient medical claims | | | | | | | 1 | 0.37% |
36 | 28 increase in flu vaccines | | | | | | | 1 | 0.37% |
37 | using longitudinal patient medical | | | | | | | 1 | 0.37% |
38 | analysis using longitudinal patient | | | | | | | 1 | 0.37% |
39 | pair analysis using longitudinal | | | | | | | 1 | 0.37% |
40 | in flu vaccines 20 increase | | | | | | | 1 | 0.37% |